KRAS Q61H [plasma membrane]

Stable Identifier
R-HSA-6802434
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
Participates
Other forms of this molecule
Modified Residues
Name
L-glutamine 61 replaced with L-histidine
Coordinate
61
PsiMod
A protein modification that effectively removes or replaces an L-glutamine.
A protein modification that effectively converts a source amino acid residue to an L-histidine.
Disease
Name Identifier Synonyms
lung cancer DOID:1324
colorectal cancer DOID:9256
pancreatic cancer DOID:1793 malignant neoplasm of tail of pancreas, pancreatic tumor, Ca body of pancreas, pancreas neoplasm, malignant neoplasm of body of pancreas, pancreatic neoplasm, malignant tumor of body of pancreas (disorder), Ca tail of pancreas (disorder), malignant neoplasm of head of pancreas, Ca tail of pancreas, malignant tumor of tail of pancreas (disorder), neoplasm of pancreas (disorder), Ca head of pancreas, Ca body of pancreas (disorder)
Cross References
Guide to Pharmacology - Targets
OpenTargets
ZINC - Substances
ZINC target
PRO
PDB
6VC8, 6O4Y, 8FMK, 5MLB, 8I5E, 4Q02, 5US4, 8TXE, 4NMM, 8V39, 6OB2, 4LDJ, 6CU6, 1KZO, 8BLR, 6WS4, 7W5R, 6BP1, 6O36, 6ZLI, 6V5L, 8AQ5, 6PTW, 6CC9, 8TBJ, 4M1S, 9BHP, 7SCW, 4WA7, 6GQW, 5XCO, 5YY1, 3GFT, 7LGI, 7U8H, 8G9P, 8B69, 8DNI, 4EPT, 8G47, 7R0M, 5UFE, 4Q01, 5MLA, 5WHD, 8I5D, 6O51, 6MQG, 8F0M, 6EPL, 8ONV, 8T74, 6EPO, 5WLB, 6FA3, 5UK9, 8DGS, 7A47, 7LC2, 8JHL, 7RP2, 7ACH, 5V6V, 8STN, 4PZZ, 6GJ7, 8AFB, 5W22, 5VPY, 4LPK, 7RT1, 7C41, 6CCH, 6GQT, 6GOE, 8T4V, 1D8D, 4EPY, 8CPR, 6ZL5, 6M9W, 2MSE, 8I5C, 8CX5, 6XHB, 8BE4, 7NY8, 8UN4, 7TLK, 8TXG, 6W4E, 8G42, 8AZX, 8T73, 6E6F, 4LYJ, 8TXH, 4DSO, 6FA4, 8V3A, 6USZ, 4PZY, 6T5U, 8AQ7, 4Q03, 9BFY, 8STM, 5VQ2, 7A1Y, 5O2S, 8TBN, 1N4P, 6V65, 8VGQ, 5VPI, 6P8Z, 6B0V, 6QUW, 8TBM, 8G4H, 4EPR, 4EPX, 5OCG, 6JTN, 8VRA, 7F0W, 6MS9, 7EW9, 6WS2, 8UN3, 8EIE, 8BE3, 6O4Z, 8FMJ, 5TB5, 8VRB, 8T75, 8QU8, 9AX6, 8YIV, 6EPP, 8JJS, 8TY2, 6H46, 5VBM, 4LYH, 7ACQ, 6T5V, 8UN5, 7KMR, 5V9O, 6GJ8, 5VPZ, 6QUU, 8JGD, 7RT4, 9BHO, 8TBL, 7C40, 6E6G, 5VQ0, 7A1W, 6JTP, 8EER, 6P8X, 6XGU, 7RPZ, 8DNK, 8VJZ, 4M1W, 6ASA, 6JTO, 8FMI, 6XHA, 5WHE, 6O46, 4DSN, 8AZR, 8YJ2, 8RRO, 6W4F, 6FA1, 4L8G, 8EZG, 8TXK, 8ECR, 7KYZ, 4OBE, 8R7X, 7ACF, 6H47, 5V9L, 6GJ5, 6TAM, 6PTS, 8TBF, 6GOF, 5OCO, 5YXZ, 8AFD, 9BI2, 4M22, 7VVB, 6GQX, 5VQ1, 7RSC, 1N4Q, 6MBU, 7A1X, 7RT5, 8PIY, 4EPW, 6UT0, 8DNJ, 6XGV, 6ARK, 6N2J, 5V71, 8EBZ, 7R0Q, 8TY8, 6EPM, 8AZZ, 7YCC, 5WHB, 6CCX, 4LUC, 4LYF, 6O53, 5USJ, 5WPM, 8R7W, 5F2E, 6OIM, 8TVK, 6USX, 6TAN, 6OB3, 8T72, 8PI0, 5VQ8, 8QW7, 7Q9U, 4M1Y, 5VP7, 9BHQ, 4TQA, 6GQY, 8TBH, 7RT3, 8QUG, 1N4R, 7RSE, 5VQ6, 7OK4, 6P8Y, 5KYK, 5O2T, 2MSC, 6VJJ, 6PQ3, 5TAR, 7TLG, 8WUL, 6MQN, 8BE5, 7YUZ, 7LC1, 8B6I, 7EWB, 6MNX, 8AZY, 8T71, 7YV1, 5UQW, 8EPW, 8DGT, 6BOF, 8TXJ, 7MQU, 4QL3, 7RP4, 6GJ6, 7KFZ, 7LZ5, 6MTA, 5UFQ, 8B78, 9BG1, 6GOG, 8EDY, 4M21, 8QW6, 8G4F, 7T1F, 6P8W, 6MBQ, 8B00, 5OCT, 1N4S, 8G9Q, 7T47, 6QUX, 4M1T, 6YR8, 6PGO, 7EYX, 8TBK, 7ROV, 6B0Y, 7O70, 5WHA, 6YXW, 6ASE, 6N2K, 7EWA, 6EPN, 6FA2, 7STF, 6T5B, 5V6S, 7MDP, 6V6F, 8TY9, 7YCE, 7ACA, 7OO7, 6WGN, 1KZP, 8AZV, 7TLE, 6F76, 7RP3, 5V9U, 8UDR, 4LRW, 8AFC, 6MBT, 4TQ9, 8QVU, 1D8E, 7SCX, 8VR9, 8DVG, 7RT2, 9BI1, 8S8C, 6PGP, 6P0Z, 6GOD, 7OK3, 6QUV, 6GOM, 4M1O, 7R0N, 2MSD, 8WTE, 4EPV, 8X6R, 4LV6
GeneCards
Pharos - Targets
Orphanet
HMDB Protein
Interactors (13)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P04049 RAF1  20 0.695 6
 UniProt:P15056 BRAF  20 0.68 5
 UniProt:Q99755 PIP5K1A  1 0.661 9
 UniProt:Q96II5 Q96II5      0.556 3
 UniProt:P50749 RASF2      0.544 2
 UniProt:P61586 RHOA  6 0.519 2
 UniProt:O75915 ARL6IP5  1 0.519 2
 UniProt:P10398 ARAF  4 0.483 2
 UniProt:Q9UQB8 BAIAP2  1 0.483 2
 UniProt:P28288 ABCD3  2 0.483 2
 UniProt:P01111 NRAS  20 0.483 2
 UniProt:Q7KZI7 MARK2      0.483 2
 ChEBI:16618 1-PHOSPHATIDYL-1D-MYO-INOSITOL 3,4,5-TRISPHOSPHATE      0.462 2
Cite Us!